Oxford Heartbeat secures ethics and HRA approval to commence clinical trials and test the effectiveness of its CE-marked medical software PreSize® Neurovascular in real-world clinical settings.
PreSize® trial receives ethics and compliance approval

Oxford Heartbeat secures ethics and HRA approval to commence clinical trials and test the effectiveness of its CE-marked medical software PreSize® Neurovascular in real-world clinical settings.
Our CEO Katerina shares her insights on how entrepreneurship has enabled her to contribute to medicine.
Our CEO Katerina, a Royal Academy of Engineering Fellow, speaks about the joys and challenges of entrepreneurship.
Acquiring CE marking for novel medical devices is often a complex process.